Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris

被引:134
|
作者
Lin, MS
Swartz, SJ
Lopez, A
Ding, X
FernandezVina, MA
Stastny, P
Fairley, JA
Diaz, LA
机构
[1] MED COLL WISCONSIN, DEPT DERMATOL, MILWAUKEE, WI USA
[2] VET ADM MED CTR, MILWAUKEE, WI 53226 USA
[3] UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 99卷 / 01期
关键词
pemphigus vulgaris; desmoglein-3; T lymphocytes; MHC II restriction; cytokines;
D O I
10.1172/JCI119130
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pemphigus vulgaris (PV) is a cutaneous autoimmune disease characterized by blister formation in the suprabasilar layers of skin and mucosae and anti-desmoglein-3 (Dsg3) autoantibodies bound to the surface of lesional keratinocytes and circulating in the serum of patients. This disease can be reproduced in neonatal mice by passive transfer of patients' IgG, indicating that humoral immunity plays an important role in the pathogenesis of PV. Currently, the role of T lymphocytes in the development of PV is not clear. Here, we report that three immunoreactive segments of the ectodomain of Dsg3 specifically induced proliferation of T cells from PV patients. We found that T lymphocytes from 13 out of 14 patients responded to at least one of three Dsg3 peptides. T cells from controls and other patient groups did not respond to these Dsg3 peptides. The major T cell population stimulated by these Dsg3 peptides was CD4 positive. Dsg3-specific T cell lines and clones were developed and were shown to express a CD4 positive memory T cell phenotype. Upon stimulation, these cell lines and clones secreted a Th2-like cytokine profile. The Dsg3 responses of these T cells were restricted to HLA-DR, and not -DQ and -DP, of the major histocompatibility complex. This information will help to elucidate the cellular immune abnormalities leading to production of pathogenic IgG autoantibodies in patients with PV.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [1] T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1
    Lin, MS
    Swartz, SJ
    Lopez, A
    Ding, X
    Fairley, JA
    Diaz, LA
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (06) : 734 - 737
  • [2] Development and characterization of desmoglein-3 specific T lymphocytes.
    Lin, MS
    Swartz, SJ
    Lopez, A
    Fairley, JA
    Diaz, LA
    [J]. FASEB JOURNAL, 1996, 10 (06): : 1764 - 1764
  • [3] Desmoglein-3 is a target autoantigen in spontaneous canine pemphigus vulgaris
    Olivry, T
    Joubeh, S
    Dunston, SM
    Nishiyama, T
    Ghohestani, RF
    [J]. EXPERIMENTAL DERMATOLOGY, 2003, 12 (02) : 198 - 203
  • [4] CLONING OF THE GENE FOR HUMAN PEMPHIGUS-VULGARIS ANTIGEN (DESMOGLEIN-3)
    SILOS, SA
    TAMAI, K
    LI, KH
    KIVIRIKKO, S
    CHRISTIANO, AM
    UITTO, J
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 558 - 558
  • [5] Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals
    Hertl, M
    Amagai, M
    Sundaram, H
    Stanley, J
    Ishii, K
    Katz, SI
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (01) : 62 - 66
  • [6] Analysis of autoreactive desmoglein 3-specific B cells in patients with pemphigus vulgaris
    Pollmann, R.
    Schmidt, T.
    Moebs, C.
    Pfuetzner, W.
    Hertl, M.
    Eming, R.
    [J]. EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E69 - E69
  • [7] T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris
    Hacker-foegen, MK
    Fairley, JA
    Lin, MS
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (06) : 1365 - 1372
  • [8] EXTRACELLULAR DOMAIN OF PEMPHIGUS-VULGARIS ANTIGEN (DESMOGLEIN-3) MEDIATES WEAK HEMOPHILIC ADHESION
    AMAGAI, M
    KARPATI, S
    KLAUSKOVTUN, V
    UDEY, MC
    STANLEY, JR
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 402 - 408
  • [9] Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris
    Veldman, C
    Höhne, A
    Dieckmann, D
    Schuler, G
    Hertl, M
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10): : 6468 - 6475
  • [10] Dynamic profiling of desmoglein 3-reactive T helper cells in pemphigus vulgaris
    Volkmann, K.
    Hinterseher, J.
    Polakova, A.
    Didona, D.
    Hertl, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B3 - B3